<DOC>
	<DOCNO>NCT00719914</DOCNO>
	<brief_summary>The main purpose research study try improve result standard treatment heart attack . Normally , heart attack patient get fast dose slow dose eptifibatide emergency room , shortly arrive . This drug usually give vein arm . However , eptifibatide also inject directly heart 's blood supply angioplasty , common procedure unblock blood vessel heart . This new way give drug studying .</brief_summary>
	<brief_title>A Safety/Efficacy Study Intracoronary Integrilin Improve Balloon Angioplasty Outcomes Treatment Heart Attacks</brief_title>
	<detailed_description>The primary objective IC-TITAN study demonstrate IC bolus eptifibatide add upstream double-bolus infusion regimen eptifibatide administer intravenously initiate early ER result significant additional clot resolution vivo compare IC injection placebo ( saline ) . The primary endpoint choose evaluate hypothesis improvement percent diameter stenosis culprit artery follow IC bolus administration eptifibatide vs. IC placebo ( saline ) assess quantitative coronary angiography ( QCA ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Eptifibatide</mesh_term>
	<criteria>Clinical Patients ( men woman ) least 18 year age Presenting ischemic chest discomfort &gt; 20 minute &lt; 6 hour duration suggestive acute myocardial infarction AND : ECG ST elevation &gt; 1mm ( &gt; 0.1mV ) two contiguous limb lead OR &gt; 2mm ( &gt; 0.2mV ) two contiguous precordial lead CLINICAL Maximal systolic blood pressure &lt; 80 mmHg AFTER initial fluid and/or pressor resuscitation Uncontrolled hypertension ( SBP &gt; 180 OR DBP &gt; 110 ) time enrollment Ventricular fibrillation ventricular tachycardia require DC cardioversion Sinus bradycardia ( HR &lt; 50/min ) , third degree advance second degree heart block . Known pregnancy New suspect new left bundle branch block BIOCHEMICAL Known thrombocytopenia ( platelet count &lt; 100,000 ) Known severe renal insufficiency ( creatinine &gt; 4.0 mg/dL ) INCREASED BLEEDING RISK Active recent ( &lt; 1 year ) bleed gastrointestinal hemorrhage Major surgery &lt; 1 month Known coagulopathy , platelet disorder history thrombocytopenia : If patient know chronic warfarin therapy , International Normalized Ratio ( INR ) must know &lt; 1.6 order patient include Known neoplasm Any history hemorrhagic cerebrovascular disorder active intracranial pathology MEDICATIONS Administration fibrinolytic agent within 7 day Known allergy contraindication eptifibatide OR aspirin OR heparin Treatment another GP IIb/IIIa inhibitor within 7 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>eptifibatide</keyword>
	<keyword>Integrilin</keyword>
	<keyword>ST-Elevation Myocardial Infarction</keyword>
	<keyword>Acute Myocardial Infarction</keyword>
</DOC>